Issued Patents 2022
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11485708 | Compounds for treatment of PD-L1 diseases | Viengkham Malathong, Pingchen Fan, Christopher W. Lange, Darren McMurtrie, Sreenivas Punna +4 more | 2022-11-01 |
| 11485737 | Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors | Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Viengkham Malathong, Sreenivas Punna +3 more | 2022-11-01 |
| 11478460 | Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors | Pingchen Fan, Christopher W. Lange, Viengkham Malathong, Sreenivas Punna, Hiroko Tanaka +2 more | 2022-10-25 |
| 11479553 | 5-5 fused rings as C5a inhibitors | Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Viengkham Malathong, Sreenivas Punna +2 more | 2022-10-25 |
| 11446289 | Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors | Shijie LI, Rajinder Singh, Ju Yang, Penglie Zhang | 2022-09-20 |
| 11384079 | 6-5 fused rings as C5a inhibitors | Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Viengkham Malathong, Sreenivas Punna +4 more | 2022-07-12 |
| 11266643 | Triaryl compounds for treatment of PD-L1 diseases | Pingchen Fan, Christopher W. Lange, Darren McMurtrie, Viengkham Malathong, Sreenivas Punna +4 more | 2022-03-08 |
| 11254695 | Soluble C5aR antagonists | Pingchen Fan, Antoni Krasinski, Shichang Miao, Sreenivas Punna, Yang Song +3 more | 2022-02-22 |